-
It's A Big Weekend For Biotech
Friday, April 17, 2015 - 4:31pm | 554Read More...This weekend is a big weekend for many biotech investors, as two major conferences get started on Saturday. Here's a breakdown of the publicly-traded names involved and a preview of what investors can expect. American Academy of Neurology Conference: April 18-25, Washington, D.C. Biogen Inc...
-
Jefferies 'Encouraged' By Biogen Idec's New Data
Tuesday, January 20, 2015 - 1:28pm | 253Read More...In a report released Tuesday, Jefferies reiterated a Buy rating and a $410 price target (set in July) for Biogen Idec Inc (NASDAQ: BIIB). The analysts say that they feel “encouraged by the incremental color on BIIB037, suggesting the results may be more robust than we [the analysts]...
-
Nomura's Takeways From Biogen Idec's Analyst Meeting
Friday, January 16, 2015 - 12:06pm | 205Read More...Ian Somaiya on Friday commented in a note that Biogen Idec Inc's (NASDAQ: BIIB) management team during a recent analyst meeting pointed to potential reasons for the recent slowdown in Ecfidera uptake. According to Somaiya, Biogen noted: "1) The burst of active switching caused by...
